251 related articles for article (PubMed ID: 16225988)
21. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
22. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.
Matsuyama A; Shiraishi T; Trapasso F; Kuroki T; Alder H; Mori M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14988-93. PubMed ID: 14630947
[TBL] [Abstract][Full Text] [Related]
23. An FHIT tumor suppressor gene?
Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI
Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339
[TBL] [Abstract][Full Text] [Related]
24. Alterations of common chromosome fragile sites in hematopoietic malignancies.
Ishii H; Furukawa Y
Int J Hematol; 2004 Apr; 79(3):238-42. PubMed ID: 15168591
[TBL] [Abstract][Full Text] [Related]
25. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
26. Chromosome arm 8p and cancer: a fragile hypothesis.
Birnbaum D; Adélaïde J; Popovici C; Charafe-Jauffret E; Mozziconacci MJ; Chaffanet M
Lancet Oncol; 2003 Oct; 4(10):639-42. PubMed ID: 14554243
[TBL] [Abstract][Full Text] [Related]
27. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
28. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
[TBL] [Abstract][Full Text] [Related]
29. WWOX, large common fragile site genes, and cancer.
Gao G; Smith DI
Exp Biol Med (Maywood); 2015 Mar; 240(3):285-95. PubMed ID: 25595185
[TBL] [Abstract][Full Text] [Related]
30. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
31. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
[TBL] [Abstract][Full Text] [Related]
32. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
34. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
[TBL] [Abstract][Full Text] [Related]
35. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
36. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
37. Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
Drusco A; Pekarsky Y; Costinean S; Antenucci A; Conti L; Volinia S; Aqeilan RI; Huebner K; Zanesi N
J Biomed Biotechnol; 2011; 2011():984505. PubMed ID: 21318118
[TBL] [Abstract][Full Text] [Related]
38. Common fragile genes.
Matsuyama A; Croce CM; Huebner K
Eur J Histochem; 2004; 48(1):29-36. PubMed ID: 15145773
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
Guidi E; Uboldi C; Ferretti L
Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
Saldivar JC; Park D
Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
